SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-17-000066
Filing Date
2017-11-07
Accepted
2017-11-07 07:04:28
Documents
3
Period of Report
2017-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k-q3x2017pressrelease.htm 8-K 25757
2 EXHIBIT 99.1 ex991-q3x2017.htm EX-99.1 1078105
3 g274847img1a02.jpg GRAPHIC 17603
  Complete submission text file 0000885590-17-000066.txt   1129579
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 171181076
SIC: 2834 Pharmaceutical Preparations